Publication:
A comparative ID migraine screener study in ophthalmology, ENT and neurology out-patient clinics

dc.contributor.authorErtaş, Mustafa
dc.contributor.authorBaykan, Betül B.
dc.contributor.authorTuncel, Deniz
dc.contributor.authorGökçe, Mustafa
dc.contributor.authorGökçay, Figen G.
dc.contributor.authorŞirin, Hadiye
dc.contributor.authorDeniz, Orhan
dc.contributor.authorÖztürk, Vesile
dc.contributor.authorİdiman, Fethi
dc.contributor.authorYıldız, Nebil
dc.contributor.authorSıva, Aksel
dc.contributor.authorSaip, Sabahattin
dc.contributor.authorGöksan, Baki
dc.contributor.authorAk, Fikri
dc.contributor.authorAluçlu, Mehmet Ufuk
dc.contributor.authorDuman, Taşkın
dc.contributor.authorMelek, İsmet Murat
dc.contributor.authorBulut, Serpil
dc.contributor.authorBerilgen, Said M.
dc.contributor.buuauthorKarlı, Necdet
dc.contributor.buuauthorZarifoğlu, Mehmet
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentNöroloji Ana Bilim Dalı
dc.contributor.scopusid6506587942
dc.contributor.scopusid6603411305
dc.date.accessioned2022-06-08T11:34:30Z
dc.date.available2022-06-08T11:34:30Z
dc.date.issued2009-01
dc.description.abstractMigraine is more likely to be misdiagnosed in patients with comorbid diseases. Not only primary care physicians, but also specialists might misdiagnose it due to the lack of diagnostic criteria awareness. The ID migraine test is a reliable screening instrument that may facilitate and accelerate migraine recognition. This study aimed to compare the prevalence and characteristics of migraine in a large sample of patients admitted to clinics of ophthalmology (OC), ear, nose and throat diseases (ENTC) and neurology (NC), as well as to validate the use of the ID migraine test in OC and ENTC settings. This was a multicentre (11 cites) study of out-patients admitting either to NC, ENTC or OC of the study sites during five consecutive working days within 1 week. From each of the clinics, 100 patients were planned to be recruited. All recruited patients were interviewed and those having a headache complaint received an ID migraine test and were examined for headache diagnosis by a neurologist, blinded to the ID migraine test result. A total of 2625 subjects were recruited. Only 1.3% of OC patients and 5.4% of ENTC patients have been admitted with a primary complaint of headache, whereas the percentage of NC patients suffering from headache was 37.6%. Whereas 138 patients (19.3%) in OC, 154 (17.3%) in ENTC and 347 (34%) in NC were found to be ID migraine test positive, 149 patients (20.8%) in OC, 142 (16%) in ENTC and 338 (33.1%) in NC were diagnosed with migraine. The sensitivity, specificity, and positive and negative predictive ratios of the ID migraine test were found to be similar in all clinics. An important fraction of the patients admitted to NC, as well as to OC and ENTC, for headache and/or other complaints were found out to have migraine by means of a simple screening test. This study validated the ID migraine test as a sensitive and specific tool in OC and ENTC, encouraging its use as a screening instrument.
dc.description.sponsorshipPfizer-Türkiye
dc.identifier.citationErtaş, M. vd. (2009). "A comparative ID migraine screener study in ophthalmology, ENT and neurology out-patient clinics". Cephalalgia, 29(1), 68-75.
dc.identifier.endpage75
dc.identifier.issn0333-1024
dc.identifier.issue1
dc.identifier.pubmed18771489
dc.identifier.scopus2-s2.0-58149216056
dc.identifier.startpage68
dc.identifier.urihttps://doi.org/10.1111/j.1468-2982.2008.01702.x
dc.identifier.urihttps://journals.sagepub.com/doi/10.1111/j.1468-2982.2008.01702.x
dc.identifier.urihttp://hdl.handle.net/11452/26971
dc.identifier.volume29
dc.identifier.wos000262222900009
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherSage Publications
dc.relation.collaborationYurt içi
dc.relation.journalCephalalgia
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectID migraine screening test
dc.subjectMigraine
dc.subjectMigraine with aura
dc.subjectAmerican migraine
dc.subjectPrimary-care
dc.subjectHeadache
dc.subjectPrevalence
dc.subjectDisability
dc.subjectDiagnosis
dc.subjectBurden
dc.subjectResponses
dc.subjectEngland
dc.subjectNeurosciences & neurology
dc.subject.emtreeAnalgesic agent
dc.subject.emtreeErgot derivative
dc.subject.emtreeNonsteroid antiinflammatory agent
dc.subject.emtreeTriptan derivative
dc.subject.emtreeAdult
dc.subject.emtreeArticle
dc.subject.emtreeClinical assessment tool
dc.subject.emtreeClinical trial
dc.subject.emtreeDiagnostic accuracy
dc.subject.emtreeDiagnostic error
dc.subject.emtreeDiagnostic value
dc.subject.emtreeFemale
dc.subject.emtreeHeadache
dc.subject.emtreeHospital admission
dc.subject.emtreeHuman
dc.subject.emtreeMajor clinical study
dc.subject.emtreeMale
dc.subject.emtreeMigraine
dc.subject.emtreeMulticenter study
dc.subject.emtreeOutpatient
dc.subject.emtreeOutpatient department
dc.subject.emtreePrediction
dc.subject.emtreePrevalence
dc.subject.emtreePrimary medical care
dc.subject.emtreeScreening test
dc.subject.emtreeSemi structured interview
dc.subject.emtreeSensitivity and specificity
dc.subject.emtreeThroat disease
dc.subject.emtreeValidation process
dc.subject.emtreeValidation study
dc.subject.scopusMigraine Disorders; Headache; Tryptamines
dc.subject.wosClinical neurology
dc.subject.wosNeurosciences
dc.titleA comparative ID migraine screener study in ophthalmology, ENT and neurology out-patient clinics
dc.typeArticle
dc.wos.quartileQ1 (Clinical neurology)
dc.wos.quartileQ2 (Neurosciences)
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Nöroloji Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Zarifoğlu_vd_2009.pdf
Size:
133.34 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: